Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study
Otolaryngology–Head and Neck Surgery · 2024-09 · 171 (3) · 833-840
DOI: 10.1002/ohn.791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 26.04.2024. Verfasst von Alma Jukic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Barrow Department of Otolaryngology, University of Arizona College of Medicine, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Bone Conduction, Hearing Aids. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Objective
The purpose of this study was to review patient demographics, indications, intraoperative findings, complications/adverse events, and audiological outcomes related to the implantation of the Osia 2 device. Study Design Retrospective case series.
Setting
Single tertiary institutional experience.
Methods
Patients who had undergone Osia 2 implantation by the senior author were identified from 2019 to present. Information was extracted from patient charts concerning patient demographics, indications for implantation, surgical findings, audiological outcomes, and adverse events.
Results
Sixty patients and 67 implants were included. The median age was 51 years ( R : 11‐92). Fifty‐five percent of patients had mixed hearing loss (HL), 30% had single‐sided deafness, and 15% had conductive HL. The mean operative time was 53.9 minutes. Only 4.5% of patients required bone polishing, and 3.0% required tissue thinning. The mean pure‐tone averages 4 gain from unaided conditions was 41.2 dB. Mean gain at 6 and 8 kHz from unaided conditions was 35.42 and 40.67 dB, respectively. Mean improvement in speech recognition threshold and word recognition score was significant in noise and quiet conditions. The all‐cause adverse event/complication rate in our series was 10.4%. The most common complications were infections (4.5%) and poorly controlled postoperative pain (3.0%). Hematomas occurred in 1.5% of patients. Reoperation was required in 4 patients; explant in 1.
Conclusion
Use of the Osia 2 device in our series has resulted in good hearing outcomes, particularly in terms of high frequency gain. Complication rates were low. To our knowledge, this is the largest study to date reporting on Osia 2 outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barrow Department of Otolaryngology, University of Arizona College of Medicine, Phoenix, Arizona, USA.
- Barrow Department of Otolaryngology, Barrow Neurological Institute, Phoenix, Arizona, USA.
ORCID-Profile: Alma Jukic
Zitieren
APA
Jukic, A., Cismas, M., Flores, N., & Stevens, S. M. (2024). Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study. Otolaryngology–Head and Neck Surgery, 171(3), 833-840. https://doi.org/10.1002/ohn.791
Vancouver
Jukic A, Cismas M, Flores N, Stevens SM. Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study. Otolaryngology–Head and Neck Surgery. 2024;171(3):833-840. doi:10.1002/ohn.791
BibTeX
@article{Jukic2024,
author = {Jukic, Alma and Cismas, Marine and Flores, Nancy and Stevens, Shawn M},
title = {Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
volume = {171},
number = {3},
pages = {833--840},
doi = {10.1002/ohn.791}
}
EUVIMED